We retrospectively evaluated 276 short-term femoral venous dialysis catheters (STFVCs) used for the collection of peripheral blood progenitor cells (PBPCs). Patients were not given any prophylactic antibiotic or anti-thrombotic therapy. Totally 877 leukapheresis sessions were performed. STFVCs were sufficient for continuous flow rate in all leukapheresis session. Side effects were detected in 30 (10.86%) STFVC practice (ecchymosis and/or hematoma in 13 (4.71%), thrombophlebitis in 5 (1.81%), bleeding in 4 (1.44%), catheters were not inserted into right femoral vein in 4 (1.44%), infection in PBPC products of 3 (1.08%) and blood receiving tip of catheter was cracked in 1 (0.36%)). Our results showed that STFVCs minimized the serious side effects such as thrombophlebitis, bleeding and infection of PBPC products. The STFVCs appeared safe and effective for PBPC collection. (C) 2007 Published by Elsevier Ltd.